CJC-1295 / Ipamorelin

CJC-1295 + Ipamorelin is a peptide combination widely studied for its effects on growth hormone–related signaling pathways and neuroendocrine regulation. This pairing has attracted significant scientific interest due to its interaction with distinct receptor systems involved in endogenous growth hormone secretion and hypothalamic-pituitary signaling mechanisms.

CJC-1295 is investigated for its activity on growth hormone-releasing hormone (GHRH) pathways, while Ipamorelin is studied for its selective interaction with ghrelin receptors. Together, these peptides provide a valuable model for researching hormone signaling dynamics, receptor-mediated responses, and endocrine regulatory processes.

Mechanism of Action

Functions through the activation of GHRH-related pathways (CJC-1295) and ghrelin receptor signaling mechanisms (Ipamorelin), influencing neuroendocrine processes associated with endogenous growth hormone regulation.

Research Areas of Interest

• Growth hormone signaling pathway research
• Neuroendocrine regulation studies
• Hypothalamic-pituitary axis investigations
• Receptor-mediated cellular signaling research
• Endocrine system function and regulation studies
• Peptide interaction and hormonal communication research

Product Information

• High-purity research peptides
• Laboratory tested for quality and identity
• Manufactured under strict quality standards
• Intended exclusively for scientific and laboratory research applications

For Research Use Only (RUO). Not for Human or Veterinary Use.